Relicab Cable Manufacturing Limited
Relicab Cable Manufacturing Limited (RELICAB.BO) Stock Competitors & Peer Comparison
See (RELICAB.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Manufacturing - Metal Fabrication Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RELICAB.BO | ₹37.30 | -1.03% | 376.2M | 27.40 | ₹1.36 | N/A |
| PTCIL.BO | ₹17,966.05 | +0.42% | 270.8B | 402.83 | ₹44.84 | N/A |
| PTCIL.NS | ₹17,949.00 | +0.29% | 270.6B | 402.57 | ₹44.83 | N/A |
| SANSERA.BO | ₹2,289.25 | -2.56% | 146.8B | 55.85 | ₹42.23 | +0.14% |
| SANSERA.NS | ₹2,289.00 | -2.41% | 146.4B | 55.79 | ₹42.18 | +0.14% |
| HAPPYFORGE.NS | ₹1,344.40 | +1.11% | 125.7B | 44.05 | ₹30.26 | +0.23% |
| GRAVITA.NS | ₹1,627.40 | +3.01% | 116.1B | 30.22 | ₹52.77 | +0.72% |
| GRAVITA.BO | ₹1,620.20 | +2.57% | 116.1B | 30.21 | ₹52.76 | +0.72% |
| RHIM.NS | ₹439.65 | -0.15% | 89.9B | 52.53 | ₹8.29 | +0.57% |
| RHIM.BO | ₹439.25 | -0.17% | 89.9B | 52.52 | ₹8.29 | +0.57% |
Stock Comparison
RELICAB.BO vs PTCIL.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, PTCIL.BO has a market cap of 270.8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while PTCIL.BO trades at ₹17,966.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas PTCIL.BO's P/E ratio is 402.83. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to PTCIL.BO's ROE of +0.05%. Regarding short-term risk, RELICAB.BO is more volatile compared to PTCIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check PTCIL.BO's competition here
RELICAB.BO vs PTCIL.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, PTCIL.NS has a market cap of 270.6B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while PTCIL.NS trades at ₹17,949.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas PTCIL.NS's P/E ratio is 402.57. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to PTCIL.NS's ROE of +0.05%. Regarding short-term risk, RELICAB.BO is more volatile compared to PTCIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check PTCIL.NS's competition here
RELICAB.BO vs SANSERA.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SANSERA.BO has a market cap of 146.8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SANSERA.BO trades at ₹2,289.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SANSERA.BO's P/E ratio is 55.85. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SANSERA.BO's ROE of +0.11%. Regarding short-term risk, RELICAB.BO is more volatile compared to SANSERA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check SANSERA.BO's competition here
RELICAB.BO vs SANSERA.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SANSERA.NS has a market cap of 146.4B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SANSERA.NS trades at ₹2,289.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SANSERA.NS's P/E ratio is 55.79. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SANSERA.NS's ROE of +0.11%. Regarding short-term risk, RELICAB.BO is more volatile compared to SANSERA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check SANSERA.NS's competition here
RELICAB.BO vs HAPPYFORGE.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, HAPPYFORGE.NS has a market cap of 125.7B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while HAPPYFORGE.NS trades at ₹1,344.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas HAPPYFORGE.NS's P/E ratio is 44.05. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to HAPPYFORGE.NS's ROE of +0.16%. Regarding short-term risk, RELICAB.BO is more volatile compared to HAPPYFORGE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check HAPPYFORGE.NS's competition here
RELICAB.BO vs GRAVITA.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, GRAVITA.NS has a market cap of 116.1B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while GRAVITA.NS trades at ₹1,627.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas GRAVITA.NS's P/E ratio is 30.22. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to GRAVITA.NS's ROE of +0.21%. Regarding short-term risk, RELICAB.BO is more volatile compared to GRAVITA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check GRAVITA.NS's competition here
RELICAB.BO vs GRAVITA.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, GRAVITA.BO has a market cap of 116.1B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while GRAVITA.BO trades at ₹1,620.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas GRAVITA.BO's P/E ratio is 30.21. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to GRAVITA.BO's ROE of +0.21%. Regarding short-term risk, RELICAB.BO is more volatile compared to GRAVITA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check GRAVITA.BO's competition here
RELICAB.BO vs RHIM.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, RHIM.NS has a market cap of 89.9B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while RHIM.NS trades at ₹439.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas RHIM.NS's P/E ratio is 52.53. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to RHIM.NS's ROE of +0.04%. Regarding short-term risk, RELICAB.BO is more volatile compared to RHIM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check RHIM.NS's competition here
RELICAB.BO vs RHIM.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, RHIM.BO has a market cap of 89.9B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while RHIM.BO trades at ₹439.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas RHIM.BO's P/E ratio is 52.52. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to RHIM.BO's ROE of +0.04%. Regarding short-term risk, RELICAB.BO is more volatile compared to RHIM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check RHIM.BO's competition here
RELICAB.BO vs KIRLFER.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, KIRLFER.NS has a market cap of 76.6B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while KIRLFER.NS trades at ₹460.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas KIRLFER.NS's P/E ratio is 18.57. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to KIRLFER.NS's ROE of +0.09%. Regarding short-term risk, RELICAB.BO is less volatile compared to KIRLFER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check KIRLFER.NS's competition here
RELICAB.BO vs KIRLFER.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, KIRLFER.BO has a market cap of 68.3B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while KIRLFER.BO trades at ₹407.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas KIRLFER.BO's P/E ratio is 20.95. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to KIRLFER.BO's ROE of +0.09%. Regarding short-term risk, RELICAB.BO is less volatile compared to KIRLFER.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check KIRLFER.BO's competition here
RELICAB.BO vs BALUFORGE.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, BALUFORGE.NS has a market cap of 50.7B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while BALUFORGE.NS trades at ₹489.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas BALUFORGE.NS's P/E ratio is 20.04. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to BALUFORGE.NS's ROE of +0.24%. Regarding short-term risk, RELICAB.BO is less volatile compared to BALUFORGE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check BALUFORGE.NS's competition here
RELICAB.BO vs PITTIENG.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, PITTIENG.NS has a market cap of 33B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while PITTIENG.NS trades at ₹915.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas PITTIENG.NS's P/E ratio is 25.29. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to PITTIENG.NS's ROE of +0.14%. Regarding short-term risk, RELICAB.BO is more volatile compared to PITTIENG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check PITTIENG.NS's competition here
RELICAB.BO vs PITTIENG.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, PITTIENG.BO has a market cap of 33B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while PITTIENG.BO trades at ₹916.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas PITTIENG.BO's P/E ratio is 25.26. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to PITTIENG.BO's ROE of +0.14%. Regarding short-term risk, RELICAB.BO is more volatile compared to PITTIENG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check PITTIENG.BO's competition here
RELICAB.BO vs SUNCLAY.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SUNCLAY.NS has a market cap of 29.8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SUNCLAY.NS trades at ₹1,433.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SUNCLAY.NS's P/E ratio is -140.96. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SUNCLAY.NS's ROE of -0.04%. Regarding short-term risk, RELICAB.BO is less volatile compared to SUNCLAY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check SUNCLAY.NS's competition here
RELICAB.BO vs KIRLOSIND.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, KIRLOSIND.BO has a market cap of 29.8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while KIRLOSIND.BO trades at ₹2,836.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas KIRLOSIND.BO's P/E ratio is 17.91. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to KIRLOSIND.BO's ROE of +0.02%. Regarding short-term risk, RELICAB.BO is more volatile compared to KIRLOSIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check KIRLOSIND.BO's competition here
RELICAB.BO vs KIRLOSIND.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, KIRLOSIND.NS has a market cap of 29.8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while KIRLOSIND.NS trades at ₹2,820.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas KIRLOSIND.NS's P/E ratio is 18.35. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to KIRLOSIND.NS's ROE of +0.02%. Regarding short-term risk, RELICAB.BO is more volatile compared to KIRLOSIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check KIRLOSIND.NS's competition here
RELICAB.BO vs AEROFLEX.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, AEROFLEX.BO has a market cap of 29.4B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while AEROFLEX.BO trades at ₹229.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas AEROFLEX.BO's P/E ratio is 59.91. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to AEROFLEX.BO's ROE of +0.14%. Regarding short-term risk, RELICAB.BO is more volatile compared to AEROFLEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check AEROFLEX.BO's competition here
RELICAB.BO vs AEROFLEX.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, AEROFLEX.NS has a market cap of 29.4B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while AEROFLEX.NS trades at ₹229.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas AEROFLEX.NS's P/E ratio is 59.68. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to AEROFLEX.NS's ROE of +0.14%. Regarding short-term risk, RELICAB.BO is more volatile compared to AEROFLEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check AEROFLEX.NS's competition here
RELICAB.BO vs SBCL.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SBCL.NS has a market cap of 26.5B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SBCL.NS trades at ₹460.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SBCL.NS's P/E ratio is 29.12. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SBCL.NS's ROE of +0.22%. Regarding short-term risk, RELICAB.BO is more volatile compared to SBCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check SBCL.NS's competition here
RELICAB.BO vs SBCL.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SBCL.BO has a market cap of 26.4B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SBCL.BO trades at ₹457.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SBCL.BO's P/E ratio is 29.04. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SBCL.BO's ROE of +0.22%. Regarding short-term risk, RELICAB.BO is more volatile compared to SBCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check SBCL.BO's competition here
RELICAB.BO vs SHBCLQ.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SHBCLQ.BO has a market cap of 23.1B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SHBCLQ.BO trades at ₹601.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SHBCLQ.BO's P/E ratio is 193.16. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SHBCLQ.BO's ROE of +0.11%. Regarding short-term risk, RELICAB.BO is more volatile compared to SHBCLQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check SHBCLQ.BO's competition here
RELICAB.BO vs MMFL.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, MMFL.NS has a market cap of 22.7B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while MMFL.NS trades at ₹462.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas MMFL.NS's P/E ratio is 23.73. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to MMFL.NS's ROE of +0.10%. Regarding short-term risk, RELICAB.BO is more volatile compared to MMFL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check MMFL.NS's competition here
RELICAB.BO vs MMFL.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, MMFL.BO has a market cap of 22.7B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while MMFL.BO trades at ₹461.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas MMFL.BO's P/E ratio is 23.76. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to MMFL.BO's ROE of +0.10%. Regarding short-term risk, RELICAB.BO is more volatile compared to MMFL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check MMFL.BO's competition here
RELICAB.BO vs DEEDEV.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, DEEDEV.NS has a market cap of 20.7B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while DEEDEV.NS trades at ₹303.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas DEEDEV.NS's P/E ratio is 25.14. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to DEEDEV.NS's ROE of +0.18%. Regarding short-term risk, RELICAB.BO is less volatile compared to DEEDEV.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check DEEDEV.NS's competition here
RELICAB.BO vs FRONTSP.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, FRONTSP.BO has a market cap of 17B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while FRONTSP.BO trades at ₹4,343.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas FRONTSP.BO's P/E ratio is 29.42. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to FRONTSP.BO's ROE of +0.44%. Regarding short-term risk, RELICAB.BO is more volatile compared to FRONTSP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check FRONTSP.BO's competition here
RELICAB.BO vs AMIC.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, AMIC.BO has a market cap of 15.9B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while AMIC.BO trades at ₹1,424.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas AMIC.BO's P/E ratio is 90.88. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to AMIC.BO's ROE of +0.45%. Regarding short-term risk, RELICAB.BO is more volatile compared to AMIC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check AMIC.BO's competition here
RELICAB.BO vs ALICON.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, ALICON.NS has a market cap of 12.9B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while ALICON.NS trades at ₹770.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas ALICON.NS's P/E ratio is 35.84. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to ALICON.NS's ROE of +0.06%. Regarding short-term risk, RELICAB.BO is more volatile compared to ALICON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check ALICON.NS's competition here
RELICAB.BO vs ALICON.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, ALICON.BO has a market cap of 12.9B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while ALICON.BO trades at ₹773.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas ALICON.BO's P/E ratio is 35.85. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to ALICON.BO's ROE of +0.06%. Regarding short-term risk, RELICAB.BO is more volatile compared to ALICON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check ALICON.BO's competition here
RELICAB.BO vs MANAKCOAT.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, MANAKCOAT.NS has a market cap of 12.1B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while MANAKCOAT.NS trades at ₹114.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas MANAKCOAT.NS's P/E ratio is 27.43. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to MANAKCOAT.NS's ROE of +0.17%. Regarding short-term risk, RELICAB.BO is more volatile compared to MANAKCOAT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check MANAKCOAT.NS's competition here
RELICAB.BO vs MANAKCOAT.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, MANAKCOAT.BO has a market cap of 12.1B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while MANAKCOAT.BO trades at ₹115.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas MANAKCOAT.BO's P/E ratio is 27.43. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to MANAKCOAT.BO's ROE of +0.16%. Regarding short-term risk, RELICAB.BO is more volatile compared to MANAKCOAT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check MANAKCOAT.BO's competition here
RELICAB.BO vs GANDHITUBE.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, GANDHITUBE.BO has a market cap of 10.8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while GANDHITUBE.BO trades at ₹893.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas GANDHITUBE.BO's P/E ratio is 15.23. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to GANDHITUBE.BO's ROE of +0.27%. Regarding short-term risk, RELICAB.BO is more volatile compared to GANDHITUBE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check GANDHITUBE.BO's competition here
RELICAB.BO vs GANDHITUBE.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, GANDHITUBE.NS has a market cap of 10.8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while GANDHITUBE.NS trades at ₹891.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas GANDHITUBE.NS's P/E ratio is 15.23. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to GANDHITUBE.NS's ROE of +0.27%. Regarding short-term risk, RELICAB.BO is more volatile compared to GANDHITUBE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check GANDHITUBE.NS's competition here
RELICAB.BO vs NELCAST.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, NELCAST.BO has a market cap of 10.2B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while NELCAST.BO trades at ₹112.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas NELCAST.BO's P/E ratio is 21.78. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to NELCAST.BO's ROE of +0.08%. Regarding short-term risk, RELICAB.BO is more volatile compared to NELCAST.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check NELCAST.BO's competition here
RELICAB.BO vs NELCAST.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, NELCAST.NS has a market cap of 10.2B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while NELCAST.NS trades at ₹111.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas NELCAST.NS's P/E ratio is 21.73. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to NELCAST.NS's ROE of +0.08%. Regarding short-term risk, RELICAB.BO is more volatile compared to NELCAST.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check NELCAST.NS's competition here
RELICAB.BO vs ELECTHERM.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, ELECTHERM.NS has a market cap of 9.5B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while ELECTHERM.NS trades at ₹723.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas ELECTHERM.NS's P/E ratio is 3.40. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to ELECTHERM.NS's ROE of -0.58%. Regarding short-term risk, RELICAB.BO is more volatile compared to ELECTHERM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check ELECTHERM.NS's competition here
RELICAB.BO vs TEMBO.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, TEMBO.NS has a market cap of 8.3B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while TEMBO.NS trades at ₹536.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas TEMBO.NS's P/E ratio is 12.67. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to TEMBO.NS's ROE of +0.42%. Regarding short-term risk, RELICAB.BO is more volatile compared to TEMBO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check TEMBO.NS's competition here
RELICAB.BO vs SGIL.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SGIL.BO has a market cap of 8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SGIL.BO trades at ₹513.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SGIL.BO's P/E ratio is 97.95. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SGIL.BO's ROE of +0.08%. Regarding short-term risk, RELICAB.BO is more volatile compared to SGIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check SGIL.BO's competition here
RELICAB.BO vs SGIL.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SGIL.NS has a market cap of 8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SGIL.NS trades at ₹516.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SGIL.NS's P/E ratio is 98.22. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SGIL.NS's ROE of +0.08%. Regarding short-term risk, RELICAB.BO is more volatile compared to SGIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check SGIL.NS's competition here
RELICAB.BO vs RAJGLOWIR.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, RAJGLOWIR.BO has a market cap of 8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while RAJGLOWIR.BO trades at ₹786.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas RAJGLOWIR.BO's P/E ratio is 32.18. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to RAJGLOWIR.BO's ROE of +0.05%. Regarding short-term risk, RELICAB.BO is less volatile compared to RAJGLOWIR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check RAJGLOWIR.BO's competition here
RELICAB.BO vs UNIABEXAL.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, UNIABEXAL.BO has a market cap of 6.3B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while UNIABEXAL.BO trades at ₹3,157.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas UNIABEXAL.BO's P/E ratio is 18.17. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to UNIABEXAL.BO's ROE of +0.25%. Regarding short-term risk, RELICAB.BO is more volatile compared to UNIABEXAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check UNIABEXAL.BO's competition here
RELICAB.BO vs PRADPME.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, PRADPME.BO has a market cap of 5.7B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while PRADPME.BO trades at ₹324.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas PRADPME.BO's P/E ratio is 21.02. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to PRADPME.BO's ROE of +0.20%. Regarding short-term risk, RELICAB.BO is more volatile compared to PRADPME.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check PRADPME.BO's competition here
RELICAB.BO vs INVPRECQ.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, INVPRECQ.BO has a market cap of 5.5B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while INVPRECQ.BO trades at ₹535.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas INVPRECQ.BO's P/E ratio is 55.65. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to INVPRECQ.BO's ROE of +0.11%. Regarding short-term risk, RELICAB.BO is more volatile compared to INVPRECQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check INVPRECQ.BO's competition here
RELICAB.BO vs TIRUPATIFL.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, TIRUPATIFL.NS has a market cap of 4.3B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while TIRUPATIFL.NS trades at ₹36.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas TIRUPATIFL.NS's P/E ratio is 71.71. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to TIRUPATIFL.NS's ROE of +0.06%. Regarding short-term risk, RELICAB.BO is less volatile compared to TIRUPATIFL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check TIRUPATIFL.NS's competition here
RELICAB.BO vs CTCL.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, CTCL.BO has a market cap of 4.2B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while CTCL.BO trades at ₹175.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas CTCL.BO's P/E ratio is 35.36. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to CTCL.BO's ROE of +0.26%. Regarding short-term risk, RELICAB.BO is more volatile compared to CTCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check CTCL.BO's competition here
RELICAB.BO vs MAGNAELQ.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, MAGNAELQ.BO has a market cap of 4.1B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while MAGNAELQ.BO trades at ₹988.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas MAGNAELQ.BO's P/E ratio is 19.75. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to MAGNAELQ.BO's ROE of +0.16%. Regarding short-term risk, RELICAB.BO is more volatile compared to MAGNAELQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check MAGNAELQ.BO's competition here
RELICAB.BO vs MANAKSIA.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, MANAKSIA.BO has a market cap of 3.9B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while MANAKSIA.BO trades at ₹60.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas MANAKSIA.BO's P/E ratio is 7.52. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to MANAKSIA.BO's ROE of +0.09%. Regarding short-term risk, RELICAB.BO is more volatile compared to MANAKSIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check MANAKSIA.BO's competition here
RELICAB.BO vs MANAKSIA.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, MANAKSIA.NS has a market cap of 3.9B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while MANAKSIA.NS trades at ₹60.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas MANAKSIA.NS's P/E ratio is 7.51. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to MANAKSIA.NS's ROE of +0.09%. Regarding short-term risk, RELICAB.BO is more volatile compared to MANAKSIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check MANAKSIA.NS's competition here
RELICAB.BO vs ROLEXRINGS.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, ROLEXRINGS.NS has a market cap of 3.8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while ROLEXRINGS.NS trades at ₹137.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas ROLEXRINGS.NS's P/E ratio is 19.57. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to ROLEXRINGS.NS's ROE of +0.18%. Regarding short-term risk, RELICAB.BO is more volatile compared to ROLEXRINGS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check ROLEXRINGS.NS's competition here
RELICAB.BO vs ROLEXRINGS.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, ROLEXRINGS.BO has a market cap of 3.8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while ROLEXRINGS.BO trades at ₹136.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas ROLEXRINGS.BO's P/E ratio is 19.55. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to ROLEXRINGS.BO's ROE of +0.18%. Regarding short-term risk, RELICAB.BO is more volatile compared to ROLEXRINGS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check ROLEXRINGS.BO's competition here
RELICAB.BO vs SIMPLEXCAS.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SIMPLEXCAS.BO has a market cap of 3.5B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SIMPLEXCAS.BO trades at ₹489.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SIMPLEXCAS.BO's P/E ratio is 17.76. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SIMPLEXCAS.BO's ROE of +0.31%. Regarding short-term risk, RELICAB.BO is less volatile compared to SIMPLEXCAS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check SIMPLEXCAS.BO's competition here
RELICAB.BO vs SYNTHFO.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SYNTHFO.BO has a market cap of 3B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SYNTHFO.BO trades at ₹1,736.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SYNTHFO.BO's P/E ratio is -2373.78. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SYNTHFO.BO's ROE of +0.14%. Regarding short-term risk, RELICAB.BO is less volatile compared to SYNTHFO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check SYNTHFO.BO's competition here
RELICAB.BO vs LGBFORGE.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, LGBFORGE.NS has a market cap of 2.8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while LGBFORGE.NS trades at ₹11.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas LGBFORGE.NS's P/E ratio is -49.75. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to LGBFORGE.NS's ROE of -0.11%. Regarding short-term risk, RELICAB.BO is less volatile compared to LGBFORGE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check LGBFORGE.NS's competition here
RELICAB.BO vs DPWIRES.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, DPWIRES.BO has a market cap of 2.4B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while DPWIRES.BO trades at ₹153.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas DPWIRES.BO's P/E ratio is 19.44. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to DPWIRES.BO's ROE of +0.05%. Regarding short-term risk, RELICAB.BO is more volatile compared to DPWIRES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check DPWIRES.BO's competition here
RELICAB.BO vs DPWIRES.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, DPWIRES.NS has a market cap of 2.4B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while DPWIRES.NS trades at ₹152.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas DPWIRES.NS's P/E ratio is 19.44. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to DPWIRES.NS's ROE of +0.05%. Regarding short-term risk, RELICAB.BO is more volatile compared to DPWIRES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check DPWIRES.NS's competition here
RELICAB.BO vs AEL.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, AEL.BO has a market cap of 1.8B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while AEL.BO trades at ₹138.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas AEL.BO's P/E ratio is 22.32. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to AEL.BO's ROE of +0.19%. Regarding short-term risk, RELICAB.BO is more volatile compared to AEL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check AEL.BO's competition here
RELICAB.BO vs LGBFORGE.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, LGBFORGE.BO has a market cap of 1.6B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while LGBFORGE.BO trades at ₹6.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas LGBFORGE.BO's P/E ratio is -76.67. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to LGBFORGE.BO's ROE of -0.11%. Regarding short-term risk, RELICAB.BO is more volatile compared to LGBFORGE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check LGBFORGE.BO's competition here
RELICAB.BO vs SIMMOND.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SIMMOND.BO has a market cap of 1.6B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SIMMOND.BO trades at ₹148.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SIMMOND.BO's P/E ratio is 12.23. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SIMMOND.BO's ROE of +0.30%. Regarding short-term risk, RELICAB.BO is more volatile compared to SIMMOND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check SIMMOND.BO's competition here
RELICAB.BO vs ALPHAIND.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, ALPHAIND.BO has a market cap of 1.6B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while ALPHAIND.BO trades at ₹156.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas ALPHAIND.BO's P/E ratio is 43.21. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to ALPHAIND.BO's ROE of +0.16%. Regarding short-term risk, RELICAB.BO is less volatile compared to ALPHAIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check ALPHAIND.BO's competition here
RELICAB.BO vs GALXBRG.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, GALXBRG.BO has a market cap of 1.5B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while GALXBRG.BO trades at ₹477.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas GALXBRG.BO's P/E ratio is 23.88. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to GALXBRG.BO's ROE of +0.06%. Regarding short-term risk, RELICAB.BO is more volatile compared to GALXBRG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check GALXBRG.BO's competition here
RELICAB.BO vs DCM.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, DCM.NS has a market cap of 1.5B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while DCM.NS trades at ₹78.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas DCM.NS's P/E ratio is 5.74. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to DCM.NS's ROE of +0.14%. Regarding short-term risk, RELICAB.BO is more volatile compared to DCM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check DCM.NS's competition here
RELICAB.BO vs DCM.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, DCM.BO has a market cap of 1.5B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while DCM.BO trades at ₹78.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas DCM.BO's P/E ratio is 5.71. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to DCM.BO's ROE of +0.14%. Regarding short-term risk, RELICAB.BO is more volatile compared to DCM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check DCM.BO's competition here
RELICAB.BO vs NATFIT.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, NATFIT.BO has a market cap of 1.5B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while NATFIT.BO trades at ₹160.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas NATFIT.BO's P/E ratio is 6.76. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to NATFIT.BO's ROE of +0.28%. Regarding short-term risk, RELICAB.BO is more volatile compared to NATFIT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check NATFIT.BO's competition here
RELICAB.BO vs KVFORGE.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, KVFORGE.BO has a market cap of 1.4B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while KVFORGE.BO trades at ₹130.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas KVFORGE.BO's P/E ratio is 20.43. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to KVFORGE.BO's ROE of +0.17%. Regarding short-term risk, RELICAB.BO is less volatile compared to KVFORGE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check KVFORGE.BO's competition here
RELICAB.BO vs COSMOFE.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, COSMOFE.BO has a market cap of 1.4B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while COSMOFE.BO trades at ₹119.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas COSMOFE.BO's P/E ratio is -42.30. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to COSMOFE.BO's ROE of -0.14%. Regarding short-term risk, RELICAB.BO is less volatile compared to COSMOFE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check COSMOFE.BO's competition here
RELICAB.BO vs MUL.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, MUL.BO has a market cap of 1.3B. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while MUL.BO trades at ₹9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas MUL.BO's P/E ratio is 4.85. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to MUL.BO's ROE of +0.68%. Regarding short-term risk, RELICAB.BO is less volatile compared to MUL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check MUL.BO's competition here
RELICAB.BO vs SMLT.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SMLT.BO has a market cap of 985.7M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SMLT.BO trades at ₹70.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SMLT.BO's P/E ratio is 25.99. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SMLT.BO's ROE of +0.03%. Regarding short-term risk, RELICAB.BO is more volatile compared to SMLT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check SMLT.BO's competition here
RELICAB.BO vs SMLT.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SMLT.NS has a market cap of 978.8M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SMLT.NS trades at ₹70.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SMLT.NS's P/E ratio is 25.81. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SMLT.NS's ROE of +0.03%. Regarding short-term risk, RELICAB.BO is more volatile compared to SMLT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check SMLT.NS's competition here
RELICAB.BO vs AUTOPINS.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, AUTOPINS.BO has a market cap of 941.7M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while AUTOPINS.BO trades at ₹156.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas AUTOPINS.BO's P/E ratio is 383.72. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to AUTOPINS.BO's ROE of +0.03%. Regarding short-term risk, RELICAB.BO is less volatile compared to AUTOPINS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check AUTOPINS.BO's competition here
RELICAB.BO vs RAPICUT.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, RAPICUT.BO has a market cap of 837.4M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while RAPICUT.BO trades at ₹152.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas RAPICUT.BO's P/E ratio is -58.39. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to RAPICUT.BO's ROE of +0.09%. Regarding short-term risk, RELICAB.BO is less volatile compared to RAPICUT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check RAPICUT.BO's competition here
RELICAB.BO vs VISHALBL.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, VISHALBL.BO has a market cap of 658.9M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while VISHALBL.BO trades at ₹60.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas VISHALBL.BO's P/E ratio is -38.16. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to VISHALBL.BO's ROE of -0.05%. Regarding short-term risk, RELICAB.BO is more volatile compared to VISHALBL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check VISHALBL.BO's competition here
RELICAB.BO vs DECANBRG.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, DECANBRG.BO has a market cap of 653.8M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while DECANBRG.BO trades at ₹299.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas DECANBRG.BO's P/E ratio is -322.10. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to DECANBRG.BO's ROE of -0.04%. Regarding short-term risk, RELICAB.BO is more volatile compared to DECANBRG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check DECANBRG.BO's competition here
RELICAB.BO vs SMFIL.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SMFIL.BO has a market cap of 617.1M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SMFIL.BO trades at ₹5.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SMFIL.BO's P/E ratio is 86.43. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SMFIL.BO's ROE of +0.06%. Regarding short-term risk, RELICAB.BO is less volatile compared to SMFIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check SMFIL.BO's competition here
RELICAB.BO vs AUSTENG.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, AUSTENG.BO has a market cap of 404.6M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while AUSTENG.BO trades at ₹119.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas AUSTENG.BO's P/E ratio is 9.26. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to AUSTENG.BO's ROE of +0.07%. Regarding short-term risk, RELICAB.BO is more volatile compared to AUSTENG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check AUSTENG.BO's competition here
RELICAB.BO vs HILTON.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, HILTON.BO has a market cap of 402.4M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while HILTON.BO trades at ₹17.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas HILTON.BO's P/E ratio is 7.07. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to HILTON.BO's ROE of +0.07%. Regarding short-term risk, RELICAB.BO is less volatile compared to HILTON.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check HILTON.BO's competition here
RELICAB.BO vs HILTON.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, HILTON.NS has a market cap of 401.1M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while HILTON.NS trades at ₹17.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas HILTON.NS's P/E ratio is 7.05. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to HILTON.NS's ROE of +0.07%. Regarding short-term risk, RELICAB.BO is less volatile compared to HILTON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check HILTON.NS's competition here
RELICAB.BO vs GANGAFORGE.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, GANGAFORGE.NS has a market cap of 399M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while GANGAFORGE.NS trades at ₹2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas GANGAFORGE.NS's P/E ratio is -12.87. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to GANGAFORGE.NS's ROE of -0.11%. Regarding short-term risk, RELICAB.BO is more volatile compared to GANGAFORGE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check GANGAFORGE.NS's competition here
RELICAB.BO vs CARNATIN.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, CARNATIN.BO has a market cap of 286.8M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while CARNATIN.BO trades at ₹82.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas CARNATIN.BO's P/E ratio is -20.74. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to CARNATIN.BO's ROE of -0.99%. Regarding short-term risk, RELICAB.BO is more volatile compared to CARNATIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check CARNATIN.BO's competition here
RELICAB.BO vs BOMBWIR.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, BOMBWIR.BO has a market cap of 245.8M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while BOMBWIR.BO trades at ₹49.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas BOMBWIR.BO's P/E ratio is -26.15. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to BOMBWIR.BO's ROE of -0.01%. Regarding short-term risk, RELICAB.BO is less volatile compared to BOMBWIR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check BOMBWIR.BO's competition here
RELICAB.BO vs ARCOTECH.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, ARCOTECH.NS has a market cap of 245.7M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while ARCOTECH.NS trades at ₹2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas ARCOTECH.NS's P/E ratio is -0.82. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to ARCOTECH.NS's ROE of +0.32%. Regarding short-term risk, RELICAB.BO is more volatile compared to ARCOTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check ARCOTECH.NS's competition here
RELICAB.BO vs SHREMETAL.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SHREMETAL.BO has a market cap of 244.4M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SHREMETAL.BO trades at ₹45.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SHREMETAL.BO's P/E ratio is 18.98. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SHREMETAL.BO's ROE of +0.13%. Regarding short-term risk, RELICAB.BO is more volatile compared to SHREMETAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check SHREMETAL.BO's competition here
RELICAB.BO vs METALFORGE.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, METALFORGE.NS has a market cap of 178.6M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while METALFORGE.NS trades at ₹4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas METALFORGE.NS's P/E ratio is -0.06. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to METALFORGE.NS's ROE of +0.13%. Regarding short-term risk, RELICAB.BO is more volatile compared to METALFORGE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check METALFORGE.NS's competition here
RELICAB.BO vs BILENERGY.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, BILENERGY.NS has a market cap of 139.5M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while BILENERGY.NS trades at ₹0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas BILENERGY.NS's P/E ratio is -0.20. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to BILENERGY.NS's ROE of +2.63%. Regarding short-term risk, RELICAB.BO is less volatile compared to BILENERGY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check BILENERGY.NS's competition here
RELICAB.BO vs SHIVAGR.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, SHIVAGR.BO has a market cap of 125.1M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while SHIVAGR.BO trades at ₹24.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas SHIVAGR.BO's P/E ratio is 26.26. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to SHIVAGR.BO's ROE of +0.06%. Regarding short-term risk, RELICAB.BO is more volatile compared to SHIVAGR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check SHIVAGR.BO's competition here
RELICAB.BO vs GALAGEX.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, GALAGEX.BO has a market cap of 118.7M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while GALAGEX.BO trades at ₹45.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas GALAGEX.BO's P/E ratio is 3.17. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to GALAGEX.BO's ROE of +1.24%. Regarding short-term risk, RELICAB.BO is more volatile compared to GALAGEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check GALAGEX.BO's competition here
RELICAB.BO vs AMFORG.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, AMFORG.BO has a market cap of 99.3M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while AMFORG.BO trades at ₹6.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas AMFORG.BO's P/E ratio is 46.00. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to AMFORG.BO's ROE of +0.03%. Regarding short-term risk, RELICAB.BO is less volatile compared to AMFORG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check AMFORG.BO's competition here
RELICAB.BO vs AANCHALISP.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, AANCHALISP.BO has a market cap of 54.3M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while AANCHALISP.BO trades at ₹19.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas AANCHALISP.BO's P/E ratio is -0.03. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to AANCHALISP.BO's ROE of -1.63%. Regarding short-term risk, RELICAB.BO is more volatile compared to AANCHALISP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for RELICAB.BO.Check AANCHALISP.BO's competition here
RELICAB.BO vs GOLKONDA.BO Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, GOLKONDA.BO has a market cap of 48.4M. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while GOLKONDA.BO trades at ₹8.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas GOLKONDA.BO's P/E ratio is 91.90. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to GOLKONDA.BO's ROE of -0.21%. Regarding short-term risk, RELICAB.BO is less volatile compared to GOLKONDA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check GOLKONDA.BO's competition here
RELICAB.BO vs ROHITFERRO.NS Comparison February 2026
RELICAB.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RELICAB.BO stands at 376.2M. In comparison, ROHITFERRO.NS has a market cap of 0. Regarding current trading prices, RELICAB.BO is priced at ₹37.30, while ROHITFERRO.NS trades at ₹28.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RELICAB.BO currently has a P/E ratio of 27.40, whereas ROHITFERRO.NS's P/E ratio is -4.58. In terms of profitability, RELICAB.BO's ROE is +0.10%, compared to ROHITFERRO.NS's ROE of +0.03%. Regarding short-term risk, RELICAB.BO is less volatile compared to ROHITFERRO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RELICAB.BO.Check ROHITFERRO.NS's competition here